Conference:
Pre-conference workshop
1 Dec 9am - 5pm
Day 1
2 Dec 8.30am - 5:30pm
Day 2
3 Dec 8.30am - 5:30pm
Post-conference workshop
4 Dec 8.30am - 5:30pm
Venue:
The Bloomsbury Hotel, London, United Kingdom
› Email a friend
› Add this to my calendar
|
|
|
Meet our media partners...
|
in-PharmaTechnologist.com
|
|
 In-PharmaTechnologist.com is a specialised news service, broadcast as a free access website and e-newsletters to registered subscribers. It guides decision-makers in product development, production and packaging in the pharmaceutical manufacturing industry by distilling facts of strategic significance or likely impact on the sector. The site has rapidly established itself as a management tool among general managers, scientists and engineers.
http://www.In-PharmaTechnologist.com
|
|
Outsourcing-Pharma.com
|
|
 Outsourcing-Pharma.com is the only free online news source covering the full spectrum of contract services to the pharmaceutical and biotechnology industries, from contract research and development through to manufacturing and commercial services. The emphasis of the publication is on practical news and information, which can be used by senior managers in the day-to-day running of their businesses.
http://www.Outsourcing-Pharma.com
|
|
Journal of Medical Economics
|
|
 The Journal of Medical Economics (JME) publishes high-quality economic assessments of novel therapeutic and device interventions for an international audience. These include:
- *economic analyses (in the form of cost minimisation, cost effectiveness, cost utility, cost benefits, cost consequence, cost of illness, burden of disease)
*Health economics methodology
*Discussions on policy issues
*Resource utilisation studies
*Disease management
*Modelling studies
*Meta-analyses of randomised controlled trials, outcomes and clinical trials data
JME specialises in the publication of studies that determine the effectiveness of medical treatment, involving measurements of therapeutic and/or preventative outcomes. Methods employed in the studies commonly involve sets of patients with comparable clinical characteristics and include measurements of mortality, morbidity and patient-reported outcomes.
Free E-Bulletin: The JME e-bulletin is targeted towards the clinical trials and pharmaceutical communications sector, with particular focus on outcomes and economics.
Sign up for your free bulletin now.
|
|
European Pharmaceutical Contractor
|
|
 The European Pharmaceutical Contractor (EPC) continually provides a dedicated platform of communication and information for the international pharmaceutical contract market. Edited by Dr Graham Hughes and established in 1997, each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. Every issue, 10,500 copies of the magazine are distributed to our specially targeted readership across the world.
For further information, please contact Danielle Levett, danielle@samedanltd.com (editorial), Jonathan Smith, jonathan@samedanltd.com (sales), or call 020 7724 3456.
Visit www.samedanltd.com for more information.
|
|
International Clinical Trials
|
|
 International Clinical Trials (ICT) is a specialist journal designed to provide global coverage of key topics pertinent to the clinical trials sector. Published quarterly, the journal offers a platform of communication and information-sharing for executive and strategic decision-makers, seeking out new trends and marketing opportunities, as well as putting a spotlight on the latest innovations coming to market.
Every issue, 10,500 copies are distributed to our specially targeted readership of strategic decision-makers within pharmaceutical companies and their contract partners, primarily in Europe, but increasingly to North America and the rest of the world.
For further information, please contact John White, john@samedanltd.com (editorial), David Hirsh, david@samedanltd.com (sales), or call 020 7724 3456.
Visit www.samedanltd.com for more information.
|
|
Piribo
|
|
 Piribo is the source for information products for the global biotechnology, healthcare and pharmaceutical industries. Use Piribo to browse thousands of business information studies, market reports and books. Find the research you need in your work. www.piribo.com
|
|
Report Buyer
|
|
 Report Buyer is the intelligent way to buy market research online. Browse and choose from a current and comprehensive range of specialised intelligence from leading publishers covering most industry and market sectors. Trusted by information professionals across the world, Report Buyer’s mission is to help you find the right business intelligence. www.reportbuyer.com
|
|
Expert Review of Clinical Pharmacology
|
|
 Advances in drug development technologies are yielding innovative new therapies, from potentially lifesaving medicines to lifestyle products. In recent years, however, the cost of developing new drugs has soared, and concerns over drug resistance and pharmacoeconomics have come to the fore. Adverse reactions experienced at the clinical trial level serve as a constant reminder of the importance of rigorous safety and toxicity testing. Furthermore the advent of pharmacogenomics and ‘individualized’ approaches to therapy will demand a fresh approach to drug evaluation and healthcare delivery.
Clinical pharmacology provides an essential role in integrating the expertise of all of the specialists and players who are active in meeting such challenges in modern biomedical practice.
Expert Review of Clinical Pharmacology provides a forum for informed debate and critical analysis of all aspects of safety, tolerability, efficacy and therapeutic applications, in addition to covering toxicity issues, adverse reactions, pharmacoeconomics and societal issues.
www.expert-reviews.com/loi/ecp
|
|
Expert opinion
|
|
 Make Better Research Decisions, Faster, with an Expert Opinion…
 The Expert Opinion series of journals provide systematic and authoritative analysis to support every stage in the pharmaceutical pipeline. With 11 internationally peer-reviewed journals, we cover the full spectrum of drug development and application.
11 phase-specific journals:
- Expert Opinion on Biological Therapy
- Expert Opinion on Drug Delivery
- Expert Opinion on Drug Discovery
- Expert Opinion on Drug Metabolism & Toxicology
- Expert Opinion on Drug Safety
- Expert Opinion on Emerging Drugs
- Expert Opinion on Investigational Drugs
- Expert Opinion on Medical Diagnostics
- Expert Opinion on Pharmacotherapy
- Expert Opinion on Therapeutic Patents
Expert Opinion on Therapeutic Targets
Our expertly crafted review articles enable the R&D community to access and track the key advances that lead to the creation of new drugs.
The distinctive “Expert Opinion” section within each review provides a personal commentary from the author on the most effective and promising strategies: an invaluable resource for decision-makers in the field.
30-day Free Trial for you, and your colleagues…
For more information and to apply for a Free 30-day Trial for your organization visit www.expertopin.com, email expertopin@informa.com or call +44 (0)20 3377 3310 today!
|
|
R&D Directions
|
|
 For more than 10 years, R&D Directions has provided the busy pharmaceutical executive with need-to-know clinical research information. Each issue delivers broad coverage and penetrating analysis of issues, events, trends, and strategies shaping drug development and pharmaceutical pipelines. Published ten times annually, R&D Directions provides exclusive content examining historical trends pertaining to and current events affecting the research of potential medicines and the companies that develop them.
To learn more about R&D Directions and other products from Canon Communications Pharmaceutical Media Group visit www.pharmalive.com or call 215-944-9800.
|
|
|
|
|
Dr Ellen Strahlman
Chief Medical Officer
GlaxoSmithKline
Dr Clive Morris
Medical Science Director
AstraZeneca
Mark Latymer
Scientific Advisor
Pfizer
Amy Sing
Associate Group Director - Post Marketing
Genentech
Professor Markus Kosch
Associate Medical Director
Wyeth Pharma
|
|
|
|
